Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175793 | SCV000227350 | uncertain significance | not provided | 2015-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000175793 | SCV001869422 | likely benign | not provided | 2020-02-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852156 | SCV002136306 | likely benign | RASopathy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372087 | SCV002688755 | likely benign | Cardiovascular phenotype | 2022-08-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004552976 | SCV004708822 | likely benign | KRAS-related disorder | 2019-06-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |